PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings
PET/CT with prostate-specific membrane antigen (PSMA)-targeted tracers has been used in the diagnosis and staging of patients with clear cell renal cell carcinoma (ccRCC). For ccRCC primary tumors, PET parameters were shown to predict histologic grade and features. The aim of this study was to corre...
Main Authors: | Falk Gühne, Philipp Seifert, Bernhard Theis, Matthias Steinert, Martin Freesmeyer, Robert Drescher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/7/1142 |
Similar Items
-
68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
by: Amir Iravani, et al.
Published: (2017-12-01) -
Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation
by: F. Schiller, et al.
Published: (2017-08-01) -
The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01) -
68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
by: Jonathan Damjanovic, et al.
Published: (2019-06-01) -
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
by: Simon K. B. Spohn, et al.
Published: (2020-12-01)